0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Viewpoint |  May 08, 2013
Investments in Infrastructure for Diverse Research Resources and the Health of the Public
Bruce M. Psaty, MD, PhD; Eric B. Larson, MD, MPH
JAMA. 2013;309(18):1895-1896. doi:10.1001/jama.2013.3445.
Medical News and Perspectives |  May 01, 2013
Judge: No Age Restriction for Emergency Contraceptive
Bridget M. Kuehn, MSJ
JAMA. 2013;309(17):1764. doi:10.1001/jama.2013.4585.
Viewpoint |  April 24, 2013
Stemming the Global Trade in Falsified and Substandard Medicines
Lawrence O. Gostin, JD; Gillian J. Buckley, MPH, PhD; Patrick W. Kelley, MD, DrPH
JAMA. 2013;309(16):1693-1694. doi:10.1001/jama.2013.3048.
Editorial |  April 24, 2013
Risks of In Utero Exposure to Valproate
Kimford J. Meador, MD; David W. Loring, PhD
JAMA. 2013;309(16):1730-1731. doi:10.1001/jama.2013.4001.
Health Agencies Update |  April 24, 2013
Diabetes Drugs Investigated
Bridget M. Kuehn, MSJ
JAMA. 2013;309(16):1674. doi:10.1001/jama.2013.4243.
Medical News and Perspectives |  April 24, 2013
Patients Given Fungus-Tainted Injections Continue to Face Uncertainty, Illness
Bridget M. Kuehn, MSJ
JAMA. 2013;309(16):1669-1670. doi:10.1001/jama.2013.3616.
Original Contribution |  April 24, 2013
Association of Perioperative β-Blockade With Mortality and Cardiovascular Morbidity Following Major Noncardiac Surgery
Martin J. London, MD; Kwan Hur, PhD; Gregory G. Schwartz, MD, PhD; et al.
JAMA. 2013;309(16):1704-1713. doi:10.1001/jama.2013.4135.
INCLUDES: , Supplemental Content
From the Centers for Disease Control and Prevention |  April 24, 2013 FREE
Notes From the Field: Emergency Department Visits and Hospitalizations for Buprenorphine Ingestion by Children—United States, 2010-2011
JAMA. 2013;309(16):1677-1678. doi:10.1001/jama.2013.975.
Viewpoint |  April 03, 2013
Approval of a Tuberculosis Drug Based on a Paradoxical Surrogate Measure
Jerry Avorn, MD
JAMA. 2013;309(13):1349-1350. doi:10.1001/jama.2013.623.
Medical News and Perspectives |  April 03, 2013
IOM: Curbing Fake Drugs Will Require National Tracking and Global Teamwork
Bridget M. Kuehn, MSJ
JAMA. 2013;309(13):1333-1334. doi:10.1001/jama.2013.2376.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  March 25, 2013
Surrogate Outcomes in Clinical Trials:  A Cautionary Tale
Staffan Svensson, MD, PhD; David B. Menkes, MD, PhD; Joel Lexchin, MSc, MD
JAMA Internal Medicine
Research Letters  |  April 22, 2013
Developing a Model for Attending Physician Workload and Outcomes
Henry J. Michtalik, MD, MPH, MHS; Peter J. Pronovost, MD, PhD; Jill A. Marsteller, PhD, MPP; et al.
JAMA Dermatology
Research Letters  |  April 01, 2013
Retrospective Review of Adverse Effects From Propranolol in Infants
Eun-Kyung M. Kwon, BA; Shawna Joachim, BA; Dawn H. Siegel, MD; et al.
JAMA Dermatology
Practice Gaps  |  April 01, 2013
Propranolol to Treat Hemangiomas of Infancy:  Safety and Side Effect Recognition
Comment on “Retrospective Review of Adverse Effects from Propranolol in Infants”
Jonathan A. Dyer, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems